SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000930413-12-006560
Filing Date
2012-12-10
Accepted
2012-12-10 16:15:40
Documents
11
Period of Report
2012-10-31

Document Format Files

Seq Description Document Type Size
1 c71861_10q.htm 10-Q 498818
2 c71861_ex31-1.htm EX-31.1 8610
3 c71861_ex31-2.htm EX-31.2 8860
4 c71861_ex32-1.htm EX-32.1 3269
5 c71861_ex32-2.htm EX-32.2 3289
  Complete submission text file 0000930413-12-006560.txt   5395998

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE enz-20121031.xml EX-101.INS 1190789
7 XBRL SCHEMA FILE enz-20121031.xsd EX-101.SCH 36865
8 XBRL CALCULATION FILE enz-20121031_cal.xml EX-101.CAL 40844
9 XBRL DEFINITION FILE enz-20121031_def.xml EX-101.DEF 204993
10 XBRL LABEL FILE enz-20121031_lab.xml EX-101.LAB 250825
11 XBRL PRESENTATION FILE enz-20121031_pre.xml EX-101.PRE 211190
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Filer) CIK: 0000316253 (see all company filings)

IRS No.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 001-09974 | Film No.: 121253284
SIC: 8071 Services-Medical Laboratories